Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve 1. Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Ltd has informed BSE that a Board Meeting is scheduled for May 23, 2026, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026, along with the Audit Report for FY2026. This is a standard regulatory intimation filed under SEBI Listing Regulations. The actual financial numbers, audit opinion, or any specific issues are not disclosed in this notice. Investors will need to wait for the meeting outcome for details on company performance.
This is a routine meeting notice with no immediate impact on the stock. The actual results and audit opinion will be released after the meeting, which could affect investor sentiment depending on the financial performance and any audit qualifications.